{
    "info": {
        "nct_id": "NCT03033303",
        "official_title": "Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin for Consolidation of First Remission of Patients With High-Risk Neuroblastoma: A Phase II Study",
        "inclusion_criteria": "* Diagnosis of NB as defined by a) histopathology (confirmed by the MSK Department of Pathology), or b) BM metastases or MIBG-avid lesion(s) plus high urine catecholamine levels.\n* Patients must have high-risk NB (MYCN-amplified stage 2/3/4/4S of any age and MYCN-nonamplified stage 4 in patients greater than 18 months of age).\n* Patients must be in first CR/VGPR\n* Patients must have a negative human anti-hu3F8 antibody (HAHA) titer\nHealthy volunteers allowed",
        "exclusion_criteria": "* Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3, with the exception of hearing loss and hematologic toxicity.\n* Active life-threatening infection.\n* Inability to comply with protocol requirements",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Patients must be in first CR/VGPR",
            "criterions": [
                {
                    "exact_snippets": "Patients must be in first CR/VGPR",
                    "criterion": "disease response status",
                    "requirements": [
                        {
                            "requirement_type": "response status",
                            "expected_value": [
                                "first complete remission (CR)",
                                "first very good partial remission (VGPR)"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have high-risk NB (MYCN-amplified stage 2/3/4/4S of any age and MYCN-nonamplified stage 4 in patients greater than 18 months of age).",
            "criterions": [
                {
                    "exact_snippets": "MYCN-amplified stage 2/3/4/4S of any age",
                    "criterion": "neuroblastoma stage and MYCN status",
                    "requirements": [
                        {
                            "requirement_type": "MYCN status",
                            "expected_value": "amplified"
                        },
                        {
                            "requirement_type": "disease stage",
                            "expected_value": [
                                "2",
                                "3",
                                "4",
                                "4S"
                            ]
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "MYCN-nonamplified stage 4 in patients greater than 18 months of age",
                    "criterion": "neuroblastoma stage and MYCN status",
                    "requirements": [
                        {
                            "requirement_type": "MYCN status",
                            "expected_value": "nonamplified"
                        },
                        {
                            "requirement_type": "disease stage",
                            "expected_value": "4"
                        },
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">",
                                "value": 18,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients must have a negative human anti-hu3F8 antibody (HAHA) titer",
            "criterions": [
                {
                    "exact_snippets": "negative human anti-hu3F8 antibody (HAHA) titer",
                    "criterion": "human anti-hu3F8 antibody (HAHA) titer",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Diagnosis of NB as defined by a) histopathology (confirmed by the MSK Department of Pathology), or b) BM metastases or MIBG-avid lesion(s) plus high urine catecholamine levels.",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of NB as defined by ... histopathology (confirmed by the MSK Department of Pathology)",
                    "criterion": "neuroblastoma diagnosis by histopathology",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "confirmation_source",
                            "expected_value": "MSK Department of Pathology"
                        }
                    ]
                },
                {
                    "exact_snippets": "BM metastases",
                    "criterion": "bone marrow metastases",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "MIBG-avid lesion(s)",
                    "criterion": "MIBG-avid lesions",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "high urine catecholamine levels",
                    "criterion": "urine catecholamine levels",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "high"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Inability to comply with protocol requirements",
            "criterions": [
                {
                    "exact_snippets": "Inability to comply with protocol requirements",
                    "criterion": "ability to comply with protocol requirements",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3, with the exception of hearing loss and hematologic toxicity.",
            "criterions": [
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "renal toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "cardiac toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "hepatic toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "neurologic toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "pulmonary toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity ≥ grade 3",
                    "criterion": "gastrointestinal toxicity",
                    "requirements": [
                        {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "grade"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Active life-threatening infection.",
            "criterions": [
                {
                    "exact_snippets": "Active life-threatening infection.",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "life-threatening"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}